109 results on '"Uehara, Takeki"'
Search Results
2. Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan
3. Prevention of post COVID-19 condition by early treatment with ensitrelvir in the phase 3 SCORPIO-SR trial
4. Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID‐19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical Trial.
5. Open-label study of the safety, pharmacokinetics, and effectiveness of a 2 mg/kg dose of baloxavir marboxil 2% granules in children
6. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial
7. Novel miRNA biomarkers for genotoxicity screening in mouse
8. Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study
9. Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats
10. Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity
11. Effects of pirfenidone in acute and sub-chronic liver fibrosis, and an initiation-promotion cancer model in the mouse
12. Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study.
13. Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil
14. Toxicogenomic biomarkers for renal papillary injury in rats
15. Investigating the transmission of baloxavir‐resistant influenza viruses from treated index patients to untreated household contacts in the BLOCKSTONE study.
16. Toxicogenomic multigene biomarker for predicting the future onset of proximal tubular injury in rats
17. Decrease in urinary creatinine in acute kidney injury influences diagnostic value of urinary biomarker-to-creatinine ratio in rats
18. A toxicogenomic approach for identifying biomarkers for myelosuppressive anemia in rats
19. Differentially Expressed MicroRNAs Provide Mechanistic Insight into Fibrosis-Associated Liver Carcinogenesis in Mice
20. Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats
21. Identification of potential genomic biomarkers for early detection of chemically induced cardiotoxicity in rats
22. Evaluation of the usefulness of biomarkers for cardiac and skeletal myotoxicity in rats
23. Identification of genomic biomarkers for concurrent diagnosis of drug-induced renal tubular injury using a large-scale toxicogenomics database
24. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice
25. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats
26. Molecular Mechanisms of Fibrosis-Associated Promotion of Liver Carcinogenesis
27. Acetaminophen-induced acute liver injury in HCV transgenic mice
28. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database
29. Interstrain Differences in the Liver Effects of Trichloroethylene in a Multistrain Panel of Inbred Mice
30. Mechanism for Prevention of Alcohol-Induced Liver Injury by Dietary Methyl Donors
31. The Japanese toxicogenomics project: Application of toxicogenomics
32. Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.
33. Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 Trial.
34. Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial.
35. Carryover effects of baloxavir acid in human nasopharyngeal/pharyngeal swabs on infectious titer testing of influenza virus.
36. Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission.
37. Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
38. A Novel Mouse Model of Acute‐on‐Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis.
39. Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis.
40. A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part).
41. Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
42. Diagnostic and predictive performance and standardized threshold of traditional biomarkers for drug-induced liver injury in rats.
43. Plasma miR-208 as a useful biomarker for drug-induced cardiotoxicity in rats.
44. Comparative Analysis of the Relationship Between Trichloroethylene Metabolism and Tissue-Specific Toxicity Among Inbred Mouse Strains: Kidney Effects.
45. Comparative Analysis of the Relationship Between Trichloroethylene Metabolism and Tissue-Specific Toxicity Among Inbred Mouse Strains: Liver Effects.
46. Identification of metabolomic biomarkers for drug-induced acute kidney injury in rats.
47. Toxicogenomics discrimination of potential hepatocarcinogenicity of non-genotoxic compounds in rat liver.
48. Genomic biomarkers for cardiotoxicity in rats as a sensitive tool in preclinical studies.
49. Comparative Nephrotoxicity of Cisplatin and Nedaplatin: Mechanisms and Histopathological Characteristics.
50. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.